Laura gained her Pharmacology BSc at Kings College London, which included a one year Industrial Placement in respiratory pharmacology at GlaxoSmithKline, and went on to complete her PhD in Translational Neuropharmacology at the Institute of Psychiatry (IoP), joint with Eli Lilly & Co in 2018. Laura is currently a Programme Manager for the Psychiatry Consortium at Medicines Discovery Catapult, working with 6 Pharma partners, 2 research charities and Wellcome to create a portfolio of projects to accelerate drug discovery in psychiatric disorders.